Treatments of prostate carcinoma and imaging follow up;Les thérapeutiques et la surveillance dans le cancer de la prostate et leurs implications sur l'imagerie

Journal de Radiologie

Volumn 87, Issue 2 C2, 2006, Pages 244-254

  Roy, C ^a   Servois, V ^a   Sauer, B ^a  

^a HÔPITAL CIVIL   (France)

Author keywords

Prostate, MR; Prostate, neoplasms; Prostate, US

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; INTERLEUKIN 2; PROSTATE SPECIFIC ANTIGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CRYOSURGERY; ECHOGRAPHY; FOLLOW UP; HUMAN; METASTASIS; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY; REVIEW; SCINTIGRAPHY; SURGICAL TECHNIQUE; TREATMENT INDICATION; AGED; BLOOD; BRACHYTHERAPY; CASE REPORT; COMPUTER ASSISTED RADIOTHERAPY; MALE; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSTATE; PROSTATE TUMOR; TIME; TUMOR RECURRENCE;

AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; BRACHYTHERAPY; COMBINED MODALITY THERAPY; CRYOSURGERY; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; TIME FACTORS; ULTRASONOGRAPHY;

EID: 33645569517     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0221-0363(06)73998-1     Document Type: Article

References (20)

1. Lu-Yao GL, Yao SL. Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet 1997;349:906-10.
2. Johansson JE, Holmberg L, Johansson S, Bergstrom R, Adami HO. Fifteen year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA 1997;277:467-71.
3. Keyser D, Kupelian PA, Zippe CD, Levin HS, Klein EA. Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10ng/ml: radiation therapy or surgery? Int J Radiat Oncol Biol Phys 1997;38:723-9.
4. Leibel SA, Fuks Z, Zelefsky MJ et al. Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. Semin Oncol 2003;30:596-615.
5. Debois M, Oyen R, Maes F et al. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 1999;45:857-65.
6. Khoo VS, Padhani AR, Tanner SF, Finnigan DJ, Leach MO, Dearnaley DP. Comparison of MRI with CT for the radiotherapy planning of prostate cancer: a feasibility study. Br J Radiol 1999;72:590-7.
7. Pasquier D, Palos G, Castelain B, Lartigau E, Rousseau J. MRI simulation for conformal radiotherapy of prostate cancer. Int J Radiat Oncol Biol Phys 2004;60:5636-7.
8. Radge H, Korb LJ, Elgamal AA, Grado GL, Nadir BS. Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up. Cancer 2000;89:135-41.
9. Roy C. Les prédictions en matière d imagerie de l'appareil uro-génital. J Radiol 2004;85:157-8.
10. Roy C. Exploration de l'appareil urinaire en IRM: développements actuels et perspectives futures. J Radiol 2004;85:171-83.
11. Bellin MF. L'imagerie urinaire au RSNA 2004. J Radiol 2005;86:862-3.
12. Poissonnier L, Gelet A, Chapelon JY et al. Résultats du traitement par ultrasons focalisés transrectaux du cancer localisé de la prostate (120 patients avec PSA ≤ 10 ng/ml). Prog Urol 2003;13:60-72.
13. Chaussy C, Thüroff G, Vallancien G et al. HIFU for the treatment of localized prostate cancer: efficacy results of the European Multicentric Study. J Urol 2001;165:388-92.
14. Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zincke H. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin Proc 2001;76:576-81.
15. D'Amico AV, Tempany CM, Schultz D et al. Comparing PSA outcome after radical prostatectomy or magnetic resonance imaging-guided partial prostatic irradiation in select patients with clinically localized adenocarcinoma of the prostate. Urology 2003;62:1063-7.
16. Wasserman NF, Kapoor DA, Hildebrandt WC et al. Transrectal ultrasound in evaluation of patients after radical prostatectomy. Part I. Normal postoperative anatomy. Radiology 1992;185:361-6.
17. Nudell DM, Wefer AE, Hricak H, Carroll PR. Imaging for recurrent prostate cancer. Radiol Clin North Am 2000;38:213-9.
18. Salomon CG, Flisak ME, Olson MC, Dudiak CM, Flanigan RC, Waters WB. Radical prostatectomy: transrectal sonographic evaluation to assess for local recurrence. Radiology 1993;189:713-9.
19. Gelet A, Chapelon JY, Poissonnier L et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 2004;63:625-9.
20. Decouvelaere M, Pommier M. Imagerie médicale: au-delà des frontières. J Radiol 2005;86:825-8.